Status:
RECRUITING
Activated Charcoal Use in Chronic Kidney Disease Patients
Lead Sponsor:
Mansoura University
Conditions:
End Stage Renal Disease (ESRD)
CKD 5D, Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Hyperphosphatemia management is initially based on restricting dietary phosphorus intake. Hyperphosphatemia is almost always seen in patients on dialysis and may contribute to progressive vascular cal...
Eligibility Criteria
Inclusion
- Adult aged ≥18 years with ESRD.
- Patients who had been on stable maintenance hemodialysis (3 times weekly) for at least 6 months.
- Patients receiving phosphate binders according to standard protocols established by kidney disease: Improving Global Outcomes (KDIGO).
Exclusion
- Severely malnourished (as diagnosed by the department's dietitian).
- Treated with overnight dialysis.
- Primary hyperparathyroidism or persistent serum levels of intact parathyroid hormone greater than 800 pg/mL.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06906874
Start Date
August 1 2025
End Date
November 1 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center
Al Mansurah, Please Select, Egypt